<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02518230</url>
  </required_header>
  <id_info>
    <org_study_id>Crossover NAVA</org_study_id>
    <nct_id>NCT02518230</nct_id>
  </id_info>
  <brief_title>Randomized Crossover of NAVA and Synchronized Intermittent Pressure Ventilation in Neonates and Infants</brief_title>
  <official_title>Respiratory Severity and Caloric Consumption on NAVA: Randomized Crossover Trial of NAVA and SIMV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Mercy Hospital Kansas City</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Mercy Hospital Kansas City</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a single center, prospective cohort crossover study comparing mechanically&#xD;
      ventilated neonates and infants on Neurally Adjusted Ventilatory Assist (NAVA) and&#xD;
      synchronized intermittent mandatory ventilation with pressure control plus pressure support&#xD;
      (SIMV(PC) + PS) modes.&#xD;
&#xD;
      This design will allow for direct comparison of two commonly used ventilator modalities in&#xD;
      the neonatal intensive care unit (NICU) to determine if one mode is superior to the other&#xD;
      with regards to respiratory mechanics and estimated energy expenditure.&#xD;
&#xD;
      It is hypothesized that neonates and infants will have improved respiratory severity score&#xD;
      (MAP X FiO2) utilizing NAVA compared to the SIMV (PC) + PS mode but will have increased&#xD;
      estimated energy expenditure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This single center, prospective cohort crossover study will involve mechanically ventilated&#xD;
      neonates and infants who are determined to be on stable ventilator settings in either the&#xD;
      NAVA or SIMV(PC) + PS modes. This design will allow for direct comparison of two commonly&#xD;
      used ventilator modalities in the neonatal intensive care unit (NICU) to determine if one&#xD;
      mode is superior to the other with regards to respiratory mechanics and energy expenditure.&#xD;
&#xD;
      Infants will be screened for stability criteria including: being stable on the ventilator in&#xD;
      either SIMV (PC) + PS or NAVA mode, on weaning or unchanged ventilatory support in previous&#xD;
      12 hours, and no need of escalation of ventilatory pressure or rate in prior 12 hours.&#xD;
&#xD;
      After screening criteria is met and consent has been obtained, data will be retrospectively&#xD;
      collected for 12 hours prior to randomization. After the subject is randomized, the infant&#xD;
      will be stabilized and data will be collected for 12 hours in the randomized mode. Data will&#xD;
      then be collected for 12 hours afterwards in the crossover mode. Data will be collected in&#xD;
      areas of patient demographics, diagnoses, indications for mechanical ventilation, hemodynamic&#xD;
      variables and respiratory parameters. While in each mode, the patient will also have indirect&#xD;
      calorimetry obtained to determine estimated energy expenditure of each mode.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory Severity Score (MAP X FiO2)</measure>
    <time_frame>12 hours and 24 hours</time_frame>
    <description>The respiratory severity score will be calculated throughout 24 hour time frame prior to and after study initiation to determine the subject's respiratory severity prior to the randomization, after randomization and after crossover. The respiratory severity score (RSS) is a simplified severity score consisting of the mean airway pressure (MAP) multiplied by the fraction of inspired oxygen (FiO2). This score ranges from 0 to 12, with a higher score indicating more severe disease.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Energy Expenditure</measure>
    <time_frame>12 hours and 24 hours</time_frame>
    <description>The subject will have indirect calorimetry performed twice during the study on each mode, 12 hours after randomization and 12 hours after crossover to determine the approximate amount of energy expenditure needed for each mode of mechanical ventilation.&#xD;
Energy expenditure is calculated by using the Harris-Benedict equation, resulted in kcal/kg per day.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Respiratory Insufficiency</condition>
  <condition>Infant, Newborn, Disease</condition>
  <arm_group>
    <arm_group_label>Neurally Adjusted Ventilatory Assist</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subject will be randomized to NAVA ventilation. Intervention is mechanical ventilation with Neurally Adjusted Ventilatory Assist for 12 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Synchronized Interm. Mandatory Assist</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subject will be randomized to SIMV(PC)PS ventilation. Intervention is mechanical ventilation with Synchronized Intermittent Mandatory Assist with Pressure Support for 12 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neurally Adjusted Ventilatory Assist</intervention_name>
    <description>The subject will be crossed over from the baseline ventilator mode to Neurally Adjusted Ventilatory Assist</description>
    <arm_group_label>Neurally Adjusted Ventilatory Assist</arm_group_label>
    <arm_group_label>Synchronized Interm. Mandatory Assist</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Synchronized Interm. Mandatory Assist</intervention_name>
    <description>The subject will be crossed over from the baseline ventilator mode to Synchronized Intermittent Mandatory Assist with Pressure Support</description>
    <arm_group_label>Neurally Adjusted Ventilatory Assist</arm_group_label>
    <arm_group_label>Synchronized Interm. Mandatory Assist</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Neonates and infants, 22 weeks gestation age or older at birth&#xD;
&#xD;
          -  Require mechanical ventilation for respiratory support in either SIMV (PC) + PS or&#xD;
             NAVA modes&#xD;
&#xD;
          -  Stable on the ventilator with a fractional inspired oxygen requirement (FiO2) of 0.60&#xD;
             or less.&#xD;
&#xD;
          -  Stable on the ventilator with weaning or unchanged ventilatory support without need of&#xD;
             escalation of ventilatory pressure or rate in prior 12 hours.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Major congenital anomalies&#xD;
&#xD;
          -  Neurologic compromise of respiratory drive&#xD;
&#xD;
          -  Phrenic nerve palsy&#xD;
&#xD;
          -  Sedated enough to suppress respiratory drive&#xD;
&#xD;
          -  Respiratory support with volume mechanical ventilation&#xD;
&#xD;
          -  Respiratory support with high frequency oscillatory ventilation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jamie L Rosterman, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Mercy Hospital Kansas City</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 3, 2015</study_first_submitted>
  <study_first_submitted_qc>August 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2015</study_first_posted>
  <results_first_submitted>December 18, 2020</results_first_submitted>
  <results_first_submitted_qc>June 29, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">July 23, 2021</results_first_posted>
  <last_update_submitted>June 29, 2021</last_update_submitted>
  <last_update_submitted_qc>June 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>NAVA Ventilation First, Then SIMV(PC)PS Ventilation</title>
          <description>Subject will be randomized to NAVA ventilation first. Intervention is mechanical ventilation with Neurally Adjusted Ventilatory Assist for 12 hours. Subjects will cross over.&#xD;
Neurally Adjusted Ventilatory Assist: The subject will be crossed over from the baseline ventilator mode to Neurally Adjusted Ventilatory Assist&#xD;
Synchronized Interm. Mandatory Assist: The subject will be crossed over from the baseline ventilator mode to Synchronized Intermittent Mandatory Assist with Pressure Support</description>
        </group>
        <group group_id="P2">
          <title>SIMV(PC)PS Ventilation First, Then NAVA Ventilation</title>
          <description>Subject will be randomized to SIMV(PC)PS ventilation first. Intervention is mechanical ventilation with Synchronized Intermittent Mandatory Assist with Pressure Support for 12 hours. Subjects will cross over&#xD;
Neurally Adjusted Ventilatory Assist: The subject will be crossed over from the baseline ventilator mode to Neurally Adjusted Ventilatory Assist&#xD;
Synchronized Interm. Mandatory Assist: The subject will be crossed over from the baseline ventilator mode to Synchronized Intermittent Mandatory Assist with Pressure Support</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>NAVA Ventilation First, Then SIMV(PC)PS Ventilation</title>
          <description>Subject will be randomized to NAVA ventilation first. Intervention is mechanical ventilation with Neurally Adjusted Ventilatory Assist for 12 hours. Subjects will cross over.&#xD;
Neurally Adjusted Ventilatory Assist: The subject will be crossed over from the baseline ventilator mode to Neurally Adjusted Ventilatory Assist&#xD;
Synchronized Interm. Mandatory Assist: The subject will be crossed over from the baseline ventilator mode to Synchronized Intermittent Mandatory Assist with Pressure Support</description>
        </group>
        <group group_id="B2">
          <title>SIMV(PC)PS Ventilation First, Then NAVA Ventilation</title>
          <description>Subject will be randomized to SIMV(PC)PS ventilation first. Intervention is mechanical ventilation with Synchronized Intermittent Mandatory Assist with Pressure Support for 12 hours. subjects will cross over.&#xD;
Neurally Adjusted Ventilatory Assist: The subject will be crossed over from the baseline ventilator mode to Neurally Adjusted Ventilatory Assist&#xD;
Synchronized Interm. Mandatory Assist: The subject will be crossed over from the baseline ventilator mode to Synchronized Intermittent Mandatory Assist with Pressure Support</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="22"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Post Menstral Age in weeks</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32" lower_limit="28" upper_limit="44"/>
                    <measurement group_id="B2" value="32" lower_limit="28" upper_limit="44"/>
                    <measurement group_id="B3" value="32" lower_limit="28" upper_limit="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Respiratory Severity Score (MAP X FiO2)</title>
        <description>The respiratory severity score will be calculated throughout 24 hour time frame prior to and after study initiation to determine the subject's respiratory severity prior to the randomization, after randomization and after crossover. The respiratory severity score (RSS) is a simplified severity score consisting of the mean airway pressure (MAP) multiplied by the fraction of inspired oxygen (FiO2). This score ranges from 0 to 12, with a higher score indicating more severe disease.</description>
        <time_frame>12 hours and 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NAVA Ventilation First, Then SIMV(PC)PS Ventilation</title>
            <description>Intervention is mechanical ventilation with Neurally Adjusted Ventilatory Assist for 12 hours.</description>
          </group>
          <group group_id="O2">
            <title>SIMV(PC)PS Ventilation First, Then NAVA Ventilation</title>
            <description>Intervention is mechanical ventilation with Synchronized Intermittent Mandatory Assist with Pressure Support for 12 hours.</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Severity Score (MAP X FiO2)</title>
          <description>The respiratory severity score will be calculated throughout 24 hour time frame prior to and after study initiation to determine the subject's respiratory severity prior to the randomization, after randomization and after crossover. The respiratory severity score (RSS) is a simplified severity score consisting of the mean airway pressure (MAP) multiplied by the fraction of inspired oxygen (FiO2). This score ranges from 0 to 12, with a higher score indicating more severe disease.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Respiratory severity score 12 h average</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.83" spread="2"/>
                    <measurement group_id="O2" value="3.82" spread="1.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Respiratory severity score 24 h average</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.46" spread="2.24"/>
                    <measurement group_id="O2" value="3.86" spread="1.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Energy Expenditure</title>
        <description>The subject will have indirect calorimetry performed twice during the study on each mode, 12 hours after randomization and 12 hours after crossover to determine the approximate amount of energy expenditure needed for each mode of mechanical ventilation.&#xD;
Energy expenditure is calculated by using the Harris-Benedict equation, resulted in kcal/kg per day.</description>
        <time_frame>12 hours and 24 hours</time_frame>
        <population>This outcome measure was not broken down by intervention as it is a median of energy expenditure for all participants enrolled. The data herein are cumulative for all study participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Overall Study</title>
            <description>Overall Study, Outcome not broken down further</description>
          </group>
        </group_list>
        <measure>
          <title>Energy Expenditure</title>
          <description>The subject will have indirect calorimetry performed twice during the study on each mode, 12 hours after randomization and 12 hours after crossover to determine the approximate amount of energy expenditure needed for each mode of mechanical ventilation.&#xD;
Energy expenditure is calculated by using the Harris-Benedict equation, resulted in kcal/kg per day.</description>
          <population>This outcome measure was not broken down by intervention as it is a median of energy expenditure for all participants enrolled. The data herein are cumulative for all study participants.</population>
          <units>kcal/kg per day</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.6" lower_limit="16.1" upper_limit="46.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 hours</time_frame>
      <desc>Escalation of ventilation settings</desc>
      <group_list>
        <group group_id="E1">
          <title>NAVA Ventilation First, Then SIMV(PC)PS Ventilation</title>
          <description>Intervention is mechanical ventilation with Neurally Adjusted Ventilatory Assist for 12 hours.</description>
        </group>
        <group group_id="E2">
          <title>SIMV(PC)PS Ventilation First, Then NAVA Ventilation</title>
          <description>Intervention is mechanical ventilation with Synchronized Intermittent Mandatory Assist with Pressure Support for 12 hours.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Winston Manimtim</name_or_title>
      <organization>Children's Mercy Hospital</organization>
      <phone>816-234-3000</phone>
      <email>wmmanimtim@cmh.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

